Lifespan Extension Could Spur Regulatory and Pharma Changes

A

Aubrey de Grey during the Longevity Investors Conference 2024

Quotes From Source

Public pressure for modernization...

Story of claim

A dramatic improvement in lifespan extension would mobilize regulatory changes and attract substantial investment from Big Pharma.

  • Goal: Mobilize regulatory change and attract Big Pharma investment.
  • Proof: Significant advances would pressure regulators to modernize and attract major investments.
  • Nuances:
    • Regulatory environment modernization
    • Increased return on investment
    • Robust Mass Rejuvenation as a goal
  • Impact on Life: Potential for faster approval and availability of new treatments.

Investments

  • Price: Estimation not available
  • Time:
  • Effort:

Risks

Regulatory hurdles may delay progress despite scientific advances.

Get Started 🚀

  • Advocate for regulatory changes to support longevity research
  • Participate in public discussions on lifespan extension

Brogevity AI can make mistakes. Check important info.


Reference Video